1. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data
   Jingjing He et al, 2021, PLOS ONE CrossRef
2. hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair
   Wei Wang et al, 2022, Molecular Medicine CrossRef
3. Blocking of autocrine IGF-1 reduces viability of human umbilical cord mesenchymal stem cells via inhibition of the Akt/Gsk-3β signaling pathway
   Qi Wang et al, 2018, Molecular Medicine Reports CrossRef
4. Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation
   Francesca Paris et al, 2022, International Journal of Molecular Sciences CrossRef
5. Addressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
   Bou-Yue Peng et al, 2018, Journal of Diabetes Research CrossRef
6. Stem Cells: Umbilical Cord/Wharton’s Jelly Derived
   John T. Walker et al, 2019, Cell Engineering and Regeneration CrossRef
7. Stem Cells: Umbilical Cord/Wharton’s Jelly Derived
   John T. Walker et al, 2020, Cell Engineering and Regeneration CrossRef
8. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus
   Xiao-Fen Lian et al, 2022, World Journal of Diabetes CrossRef
9. Transplantation of stromal-derived factor 1α and basic fibroblast growth factor primed insulin-producing cells reverses hyperglycaemia in diabetic rats
   Muhammad Sohail Anjum et al, 2017, Growth Factors CrossRef
10. Programmable dual responsive system reconstructing nerve interaction with small-diameter tissue-engineered vascular grafts and inhibiting intimal hyperplasia in diabetes
    Yanzhao Li et al, 2022, Bioactive Materials CrossRef